Nuveen, LLC Prothena Corp Public LTD CO Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Nuveen, LLC holds 149,961 shares of PRTA stock, worth $1.14 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
149,961Holding current value
$1.14 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PRTA
# of Institutions
194Shares Held
39.2MCall Options Held
601KPut Options Held
259K-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$88.2 Million7.5% of portfolio
-
Wellington Management Group LLP Boston, MA5.2MShares$39.6 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.86MShares$29.4 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.69MShares$28 Million0.01% of portfolio
-
Armistice Capital, LLC New York, NY2.24MShares$17 Million0.44% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $357M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...